---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-24-000127"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:19:05.495812+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cyrus Taraporevala elected to Pfizer's Board of Directors effective June 27, 2024

## Summary
- Taraporevala, former President & CEO of State Street Global Advisors (2017-2022), joins Board.
- Appointed to Audit Committee and Compensation Committee immediately.
- Also serves on boards of Shell plc and Bridgepoint Group plc.
- Background includes roles at Fidelity, BNY Mellon, Legg Mason, Citigroup, and McKinsey.

## SEC filing metadata
- accession: 0000078003-24-000127
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/0000078003-24-000127-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/pfe-20240627.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-24-000127
- JSON: https://secwatch.observer/filing/0000078003-24-000127.json
- Plain text: https://secwatch.observer/filing/0000078003-24-000127.txt

## Key facts
- Executive change
  Cyrus Taraporevala was elected as Director at PFIZER INC.
  - Action: elected
  - Role: Director
  source text: elected Cyrus Taraporevala to serve as a member of the Company’s Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/0000078003-24-000127-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.